This inventor holds 1 USPTO granted patent. Top assignee: Syntex Pharmaceuticals, Ltd.. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Francedillaoise Gellibert: Innovator in Pharmaceutical Chemistry
Introduction
Francedillaoise Gellibert is a notable inventor based in Cachan, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical treatments. His work focuses on innovative solutions to complex health issues.
Latest Patents
Gellibert holds a patent for "Heterocyclic derivatives in the treatment of ischaemia and related." This patent includes compounds of the formula: ##STR1## wherein m is 0 or 1. This invention represents a step forward in addressing ischaemia, a condition that affects blood flow and can lead to serious health complications.
Career Highlights
Francedillaoise Gellibert is associated with Syntex Pharmaceuticals, Ltd., where he has been instrumental in advancing research and development in pharmaceutical products. His expertise in heterocyclic chemistry has positioned him as a valuable asset in the industry.
Collaborations
Throughout his career, Gellibert has collaborated with esteemed colleagues such as Jean-Claude G Pascal and Gary Mccort. These partnerships have fostered innovation and have contributed to the successful development of new pharmaceutical compounds.
Conclusion
Francedillaoise Gellibert's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the treatment of ischaemia, highlight the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile